A new model of Gaucher disease advances scientific understanding of a rare disorder and enables further study of related conditions.
Find out how Toxicology in the 21st Century researchers have developed faster, cheaper and more effective testing methods to analyze the effects of chemicals on human health.
NCATS chemical screening resources enable studies on potential treatments for Parkinson's and related diseases.
NCATS researchers provided crucial pre-clinical resources for Aes-103, a potential therapeutic to treat sickle cell disease.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
Creating chemical probes to treat diabetes, stroke and thrombosis.
NIH launches program to explore poorly understood genes.
- Request for Information (RFI): Input on Information Resources for Data-Related Standards Widely Used in Biomedical Science
- Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2015-1)
- Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
- More Funding & Notices...
- Sickle Cell Drug Candidate under Development • Journal of the American Medical Association
- New ‘Biochips’ That Mimic Our Bodies Could Speed Development of Drugs • Wired
- Brain Networks 'Hyper-Connected' in Young Adults Who Had Depression • University of Illinois at Chicago
- More News & Events...